Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (No. 333-251105, No. 333-263913 and No. 333-270655) on Form S-8 and in the registration statement (No. 333-261970) on Form S-3 of our report dated March 28, 2024,
with respect to the consolidated financial statements of Kinnate Biopharma Inc.
|
/s/ KPMG LLP
|
| |
|
San Diego, California
|
|
March 28, 2024
|